Overview

Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic in Patients With Type 2 Diabetes

Status:
NOT_YET_RECRUITING

Trial end date:
2029-02-01

Target enrollment:

Participant gender:

Summary

This study is a multicenter, randomized, open, parallel-controlled, Phase III clinical study aimed to evaluate the efficacy and safety of semaglutide injection and Ozempic in patients with type 2 diabetes.

Phase:

PHASE3

Details

Lead Sponsor:

Shandong New Time Pharmaceutical Co., LTD

Treatments:

semaglutide